Best-performing stocks in the S&P 500 moneyweek.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneyweek.com Daily Mail and Mail on Sunday newspapers.
Biotech company COMPASS Pathways has produced a drug to treat depression based on the psychedelic substance found in magic mushrooms. Bruce Packard assesses the stock's potential for investors.
Biotech company COMPASS Pathways has produced a drug to treat depression based on the psychedelic substance found in magic mushrooms. Bruce Packard assesses the stock's potential for investors.
Many fund managers talk up their green credentials to sell funds, but buying an environmental and sustainability specialist is the best way to profit from the boom, says Bruce Packard.